Breast cancer survivor offers wisdom at Faulkner satellite center
Call 877-422-3324 today to make an appointment
Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.
Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.
Toll-Free Number866-408-DFCI (3324)
Discover the ways to give and how to get involved to support Dana-Farber.
Poet Richard Fox gains insight – and material – through cancer treatment
A family faces cancer in an unfamiliar city – with help
Choosing mastectomy or not: Studying young women's surgical choices
Jeff's targeted therapy has kept his advanced lung cancer at bay.
Status: RecruitingPhase: N/ADiagnosis: Pediatric NeuroblastomaNCT ID: NCT00904241
(View complete trial on ClinicalTrials.gov)
DFCI Protocol ID: 00-272
This research trial studies biomarkers in tumor tissue samples from patients with newly diagnosed neuroblastoma or ganglioneuroblastoma. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer.
Conducting Institutions: Dana-Farber Cancer Institute, Children's Hospital Boston, Massachusetts General Hospital
Overall PI: Suzanne Shusterman, MD,
Dana-Farber Cancer Institute
Contacts: Dana-Farber Cancer Institute:
Childrens Hospital Pediatric Clinical Translation Investigation Program CTIP,
email@example.comMassachusetts General Hospital:
Cancer Trials Call Center, 877-789-6100